Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FE0KW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $141,880
Award facts
- Contract value 100% obligated
- $141,879.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $141,879.55 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. Dupixent is a biologic medication primarily used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis with nasal polyps.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor contract valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The SPE2DX contract enables the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems to procure a wide range of pharmaceutical products, specialty medications, vaccines, and medical supplies. AmerisourceBergen's position as a prime vendor on this critical medical supply chain vehicle reflects its established capability to meet federal procurement requirements and support military readiness through reliable pharmaceutical logistics.
Quick answers
Who was awarded contract SPE2DB25FE0KW?
SPE2DB25FE0KW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FE0KW worth?
The government has obligated $141,880 on SPE2DB25FE0KW.
Is contract SPE2DB25FE0KW an order under another contract?
Yes. SPE2DB25FE0KW is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE0KW competed?
The extent of competition for SPE2DB25FE0KW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award